Cargando…

Specificity Assessment of CRISPR Genome Editing of Oncogenic EGFR Point Mutation with Single-Base Differences

In CRISPR genome editing, CRISPR proteins form ribonucleoprotein complexes with guide RNAs to bind and cleave the target DNAs with complete sequence complementarity. CRISPR genome editing has a high potential for use in precision gene therapy for various diseases, including cancer and genetic disord...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Taegeun, Kim, Hanseop, Kim, Jeong Hee, Kim, Yong Jun, Lee, Seung Hwan, Ham, Byung-Joo, Hur, Junho K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982904/ https://www.ncbi.nlm.nih.gov/pubmed/31877894 http://dx.doi.org/10.3390/molecules25010052

Ejemplares similares

Prediction-based highly sensitive CRISPR off-target validation using target-specific DNA enrichment
por: Kang, Seung-Hun, et al.
Publicado: (2020)

Author Correction: Prediction-based highly sensitive CRISPR off-target validation using target-specific DNA enrichment
por: Kang, Seung-Hun, et al.
Publicado: (2021)

Highly specific chimeric DNA-RNA-guided genome editing with enhanced CRISPR-Cas12a system
por: Kim, Hanseop, et al.
Publicado: (2022)

Development of CRISPR technology for precise single-base genome editing: a brief review
por: Lee, Hyomin K., et al.
Publicado: (2021)

CRISPR-Cpf1 Activation of Endogenous BMP4 Gene for Osteogenic Differentiation of Umbilical-Cord-Derived Mesenchymal Stem Cells
por: Choi, Jaehoon, et al.
Publicado: (2020)

CRISPR prime editing for unconstrained correction of oncogenic KRAS variants
por: Jang, Gayoung, et al.
Publicado: (2023)

CRISPR-edit point mutant allele detection (CEPAD)-PCR method for rapid screening of CRISPR edited point mutations
por: Trimmer, Kenneth, et al.
Publicado: (2021)

CRISPR and Target-Specific DNA Endonucleases for Efficient DNA Knock-in in Eukaryotic Genomes
por: Lee, Seung Hwan, et al.
Publicado: (2018)

Generation of lung cancer cell lines harboring EGFR T790M mutation by CRISPR/Cas9-mediated genome editing
por: Park, Mi-Young, et al.
Publicado: (2017)

Enhancement of target specificity of CRISPR–Cas12a by using a chimeric DNA–RNA guide
por: Kim, Hanseop, et al.
Publicado: (2020)

CRISPR-clear imaging of melanin-rich B16-derived solid tumors
por: Schubert, Rajib, et al.
Publicado: (2023)

Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing
por: Sayed, Shady, et al.
Publicado: (2022)

Expansion of the prime editing modality with Cas9 from Francisella novicida
por: Oh, Yeounsun, et al.
Publicado: (2022)

Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2
por: Bae, Kieun, et al.
Publicado: (2022)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
por: Sinha, Sanju, et al.
Publicado: (2021)

Ectopic transient overexpression of OCT-4 facilitates BMP4-induced osteogenic transdifferentiation of human umbilical vein endothelial cells
por: Kim, Seung Hyun L, et al.
Publicado: (2020)

An anti-EGFR × cotinine bispecific antibody complexed with cotinine-conjugated duocarmycin inhibits growth of EGFR-positive cancer cells with KRAS mutations
por: Jin, Junyeong, et al.
Publicado: (2018)

Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
por: Sinha, Sanju, et al.
Publicado: (2022)

Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3′-overhang
por: Bin Moon, Su, et al.
Publicado: (2018)

Recent advances in the CRISPR genome editing tool set
por: Moon, Su Bin, et al.
Publicado: (2019)

An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma
por: Kim, Yeseul, et al.
Publicado: (2023)

KIF5B-RET Fusion gene may coincide oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas
por: Kim, Jeong-Oh, et al.
Publicado: (2015)

Web-based design and analysis tools for CRISPR base editing
por: Hwang, Gue-Ho, et al.
Publicado: (2018)

CRISPR-Mediated Base Editing: From Precise Point Mutation to Genome-Wide Engineering in Nonmodel Microbes
por: Li, Mengyuan, et al.
Publicado: (2022)

CCN5 Reduces Ligamentum Flavum Hypertrophy by Modulating the TGF‐β Pathway
por: Ye, Sunghyeok, et al.
Publicado: (2019)

Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR
por: Ha, Sang Yun, et al.
Publicado: (2015)

Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
por: Koo, Taeyoung, et al.
Publicado: (2017)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

Human Motor Neurons With SOD1-G93A Mutation Generated From CRISPR/Cas9 Gene-Edited iPSCs Develop Pathological Features of Amyotrophic Lateral Sclerosis
por: Kim, Byung Woo, et al.
Publicado: (2020)

EGFR mutations in sinonasal squamous tumors: oncogenic and therapeutic implications
por: Udager, Aaron M., et al.
Publicado: (2015)

CReVIS-Seq: A highly accurate and multiplexable method for genome-wide mapping of lentiviral integration sites
por: Kim, Heon Seok, et al.
Publicado: (2021)

Identification of EGFR Mutations by Immunohistochemistry with EGFR Mutation–Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma
por: Kim, Chi Hong, et al.
Publicado: (2015)

Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing
por: Park, Hanseul, et al.
Publicado: (2020)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer
por: Shin, Dong Hoon, et al.
Publicado: (2023)

Multiplexed CRISPR gene editing in primary human islet cells with Cas9 ribonucleoprotein
por: Bevacqua, Romina J., et al.
Publicado: (2023)

Expanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations
por: Choi, Eunyoung, et al.
Publicado: (2022)

PE-Designer and PE-Analyzer: web-based design and analysis tools for CRISPR prime editing
por: Hwang, Gue-Ho, et al.
Publicado: (2021)

CRISPR base editing applications for identifying cancer-driving mutations
por: Pal, Martin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9702h1d4mr6f81d4lpr1uvcekr